Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Primary Ovarian Insufficiency 1Peripheral Nervous System Diseases 1Ototoxicity 1Neurotoxicity Syndromes 1Insulin Resistance 1Hyperandrogenism 1Breast Cancer Female 1

Interventions

Metformin 18Inositol 5Exercise 4Pioglitazone 3Insulin 3Ethinyl Estradiol 3drospirenone and ethinyl estradiol combination 2Surveys and Questionnaires 2Cyproterone Acetate 2Acupuncture Therapy 2ziprasidone 1salicylsalicylic acid 1maltodextrin 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1Zoledronic Acid 1Waist-Hip Ratio 1Waist Circumference 1Vitamin D 1Time 1Thioctic Acid 1Tablets 1Sulfasalazine 1Sugars 1Sodium-Glucose Transporter 2 Inhibitors 1Sodium Salicylate 1Saline Solution 1Resistance Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Insulin Resistance × Thioctic Acid × Clear all
NCT00505427 2013-07-01

Alpha Lipoic Acid and Polycystic Ovary Syndrome

University of California, San Francisco

Phase 1 Completed
22 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡